RT Journal Article
SR Electronic
T1 Effects of the COVID-19 pandemic on sympathectomies in Brazil’s public health system
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.05.13.24307276
DO 10.1101/2024.05.13.24307276
A1 Sorbello, Carolina Carvalho Jansen
A1 Portela, Felipe Soares Oliveira
A1 Girardi, Giulia St. Sève
A1 da Silva, Marcelo Fiorelli Alexandrino
A1 Teivelis, Marcelo Passos
A1 Wolosker, Nelson
YR 2024
UL http://medrxiv.org/content/early/2024/05/13/2024.05.13.24307276.abstract
AB Objective To analyze and compare the number of sympathectomies for the treatment of hyperhidrosis in the public health system (SUS - Unified Health System) before, during, and after the peak of the COVID-19 pandemic in Brazil.Method A retrospective cross-sectional study, in accordance with the guidelines of the Research Ethics Committee, which analyzed the number of elective surgical procedures performed in SUS-Brazil, including the number of thoracic sympathectomies for the treatment of hyperhidrosis, in the 2 years prior to the COVID-19 pandemic (2018 and 2019) as well as in the 2 years of maximum prevalence (2020-2021) and in the 2 years following the peak of cases (2022-2023). The data analyzed was obtained from the database of the Department of Informatics of the Unified Health System (DATASUS).Results The number of thoracic sympathectomies performed in the SUS during the years 2020 and 2021 significantly decreased, probably secondary to the allocation of resources to the care of COVID-19 patients. This was followed by a lower than expected increase in the number of sympathectomies compared to pre-pandemic data.Conclusion The volume of sympathectomies, and consequently the surgical treatment of hyperhidrosis patients dependent on the SUS, have been extremely affected by the COVID-19 pandemic and remain in slow recovery, with no short-term prospect of returning to previous figures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo author has conflict of interest. This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data was extracted from the DATASUS portal (Department of Information and Informatics of the Brazilian Unified Health System) where it is stored anonymously and is available for free consultation. https://datasus.saude.gov.br/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript All data analyzed are available online at https://datasus.saude.gov.br/ https://datasus.saude.gov.br/